Pediatric inflammatory bowel disease in South India
Related Experiment Video
Updated: Jun 21, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
B Avinash1, A K Dutta, A Chacko
1Department of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
Insights
Inflammatory bowel disease (IBD) affects children, with Crohn's disease and ulcerative colitis being the main types. Diagnosis delays are common, and nutritional issues are more prevalent in Crohn's disease patients.
Area of Science:
- Pediatric gastroenterology
- Digestive health
- Chronic illness in children
Background:
- Inflammatory bowel disease (IBD) encompasses chronic conditions like Crohn's disease and ulcerative colitis.
- Pediatric IBD represents a significant, though relatively small, percentage of new diagnoses.
- Timely diagnosis and management are crucial for pediatric patients with IBD.
Purpose of the Study:
- To analyze the characteristics of pediatric inflammatory bowel disease diagnoses over an eight-year period.
- To identify the prevalence of Crohn's disease and ulcerative colitis in children.
- To investigate diagnostic delays and nutritional outcomes in pediatric IBD.
Main Methods:
- Retrospective review of 34 pediatric patients diagnosed with IBD over eight years.
- Categorization of diagnoses into Crohn's disease and ulcerative colitis.
- Assessment of diagnostic timelines and nutritional status.
Main Results:
- Out of 34 pediatric IBD cases, 23 were Crohn's disease and 11 were ulcerative colitis.
- Pediatric IBD constituted 7% of annual new IBD cases.
- A median diagnostic delay of 15 months was observed.
- Nutritional impairment was significantly more frequent in children with Crohn's disease compared to ulcerative colitis.
Conclusions:
- Pediatric IBD is predominantly Crohn's disease, with significant diagnostic delays impacting outcomes.
- Early detection and intervention are critical to mitigate nutritional deficits in pediatric Crohn's disease.
- Further research into optimizing the diagnostic pathway for pediatric IBD is warranted.
Abstract:
Among 34 children diagnosed to have inflammatory bowel disease (IBD) over past 8 years, 23 had Crohns disease and 11 had ulcerative colitis. Pediatric patients accounted for 7% of new cases of IBD seen annually. Median delay in diagnosis was 15 months. Nutritional impairment was significantly more common in Crohns disease.
Related Concept Videos
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
